Randomised comparative trial of Bupivacaine and 2-Chloroprocaine by caesarean section.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON22342

Enrollment

Registered

2013-07-16

Start date

2013-07-15

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C-section, Chloroprocaine, intrathecal, Bupivacaine, caesarean, Sufentanil, Ampres, Marcaine.

Interventions

Measurement of sensory and motor block, hemodynamic monitoring during procedure, feeling of nausea and vomitting, feeling of pain, relief of motor block.

Eligibility

Inclusion criteria

Inclusion criteria: All healthy(ASA I-II) women with an uncomplicated singleton pregnancy between 18-40 y undergoing a planned caesarian. Pregnancy > or equal to 37 weeks.

Exclusion criteria

Exclusion criteria: Women who belong to ASA III-IV classification, BMI >35, length <150 cm, foetus with known fetal abnormality, pregnancy less than 37 weeks, known allergy for the used local anesthetics and (pre) eclampsia.

Design outcomes

Primary

Measure	Time frame
Earlier releave of motor block (less then 90' after injection).	—

Contacts

Public ContactVeerle Mossevelde, van

Laarbeeklaan 101

veerle.vanmossevelde@uzbrussel.be+32 (0)2 4763134

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)